Article
Plasma progranulin levels for frontotemporal dementia in clinical practice: a 10-year French experience.
Neurobiology of aging - 1 Jul 2020
Sellami Leila, Rucheton Benoît, Ben Younes Imen, Camuzat Agnès, Saracino Dario, Rinaldi Daisy, Epelbaum Stephane, Azuar Carole, Levy Richard, Auriacombe Sophie, Hannequin Didier, Pariente Jérémie, Barbier Mathieu, Boutoleau-Bretonnière Claire, Couratier Philippe, Pasquier Florence, Deramecourt Vincent, Sauvée Mathilde, Sarazin Marie, Lagarde Julien, Roué-Jagot Carole, Forlani Sylvie, Jornea Ludmila, David Isabelle, LeGuern Eric, Dubois Bruno, Brice Alexis, Clot Fabienne, Lamari Foudil, Le Ber Isabelle
Abstract excerpt
GRN mutations are frequent causes of familial frontotemporal degeneration. Although there is no clear consensual threshold, plasma progranulin levels represent an efficient biomarker for predicting GRN mutations when decreased. We evaluated plasma levels to determine whether it could also predict age at onset, clinical phenotype, or disease progression in 160 GRN carriers. Importantly, progranulin levels were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
